SAA1 and hemophagocytic syndrome: SAA-1, a classical acute-phase reactant, was selected because in our proteomic data it showed upregulation in sepsis compared with both healthy donors and HLH, while remaining largely unchanged between HLH and healthy donors, suggesting its value as a differential marker for both diseases.